JP2014509189A5 - - Google Patents

Download PDF

Info

Publication number
JP2014509189A5
JP2014509189A5 JP2013551314A JP2013551314A JP2014509189A5 JP 2014509189 A5 JP2014509189 A5 JP 2014509189A5 JP 2013551314 A JP2013551314 A JP 2013551314A JP 2013551314 A JP2013551314 A JP 2013551314A JP 2014509189 A5 JP2014509189 A5 JP 2014509189A5
Authority
JP
Japan
Prior art keywords
colon cancer
nucleic acid
subject
threshold
expression level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013551314A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014509189A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/022594 external-priority patent/WO2012103250A2/en
Publication of JP2014509189A publication Critical patent/JP2014509189A/ja
Publication of JP2014509189A5 publication Critical patent/JP2014509189A5/ja
Pending legal-status Critical Current

Links

JP2013551314A 2011-01-25 2012-01-25 結腸ガン遺伝子発現シグネチャーおよび使用方法 Pending JP2014509189A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161435922P 2011-01-25 2011-01-25
US61/435,922 2011-01-25
PCT/US2012/022594 WO2012103250A2 (en) 2011-01-25 2012-01-25 Colon cancer gene expression signatures and methods of use

Publications (2)

Publication Number Publication Date
JP2014509189A JP2014509189A (ja) 2014-04-17
JP2014509189A5 true JP2014509189A5 (OSRAM) 2015-03-05

Family

ID=46581385

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013551314A Pending JP2014509189A (ja) 2011-01-25 2012-01-25 結腸ガン遺伝子発現シグネチャーおよび使用方法

Country Status (14)

Country Link
US (1) US10196691B2 (OSRAM)
EP (1) EP2668296B1 (OSRAM)
JP (1) JP2014509189A (OSRAM)
KR (1) KR20140006898A (OSRAM)
CN (1) CN103403543B9 (OSRAM)
AU (1) AU2012209074A1 (OSRAM)
BR (1) BR112013018924A2 (OSRAM)
CA (1) CA2825218A1 (OSRAM)
EA (1) EA201391074A1 (OSRAM)
IL (1) IL227643A0 (OSRAM)
MX (1) MX2013008367A (OSRAM)
SG (1) SG192108A1 (OSRAM)
WO (1) WO2012103250A2 (OSRAM)
ZA (1) ZA201305024B (OSRAM)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
SI2556171T1 (sl) 2010-04-05 2016-03-31 Prognosys Biosciences, Inc. Prostorsko kodirane biološke analize
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
US20130074201A1 (en) * 2011-09-16 2013-03-21 The Johns Hopkins University Cancer-specific genetic rearrangements
EP4592400A3 (en) * 2012-10-17 2025-10-29 10x Genomics Sweden AB Methods and product for optimising localised or spatial detection of gene expression in a tissue sample
EP4219745B1 (en) 2013-06-25 2025-09-03 Prognosys Biosciences, Inc. Spatially encoded biological assays using a microfluidic device
US9652722B1 (en) * 2013-12-05 2017-05-16 The Mathworks, Inc. Methods and systems for robust supervised machine learning
DK3108254T3 (en) * 2014-02-17 2019-03-11 Ventana Med Syst Inc G-ALFA INTERACTING WITH A VESICEL-ASSOCIATED PROTEIN (GIV) AS A PREDICTIVE MARKER IN A STAGE II COLORECTAL CANCER
WO2015155765A1 (en) * 2014-04-10 2015-10-15 Bio-Marcare Technologies Ltd. Methods and kits for identifying pre-cancerous colorectal polyps and colorectal cancer
DK3901281T4 (da) 2015-04-10 2025-10-20 Illumina Inc Rumligt adskilt, multipleks nukleinsyreanalyse af biologiske prøver
CN108020672A (zh) * 2016-11-03 2018-05-11 中国医学科学院基础医学研究所 检测rhbdd1蛋白的elisa方法及试剂盒
WO2018107023A1 (en) * 2016-12-08 2018-06-14 Dana-Farber Cancer Institute, Inc. Metabolic profiling of fixed samples
CN107158388B (zh) * 2017-07-11 2021-03-23 上海市第一人民医院 MIIP pS303阻断剂在制备抗肿瘤药物中的应用
DK3743534T3 (da) * 2018-01-22 2022-06-20 Liquid Biopsy Res Llc Fremgangsmåde til påvisning af coloncancer og behandlingsovervågning
US12498372B2 (en) 2018-04-12 2025-12-16 Board Of Regents, The University Of Texas System Biomarker for detecting cancer
JP2020028278A (ja) * 2018-08-24 2020-02-27 国立大学法人九州大学 被検体に生じるイベントを予測するための判別器の生成方法、及び前記判別器を用いた被検体の層別化方法
CN111321220A (zh) * 2018-12-14 2020-06-23 中国医学科学院肿瘤医院 用于检测直肠癌放化疗敏感性的组合物、微阵列和计算机系统
CN110079607B (zh) * 2019-04-04 2022-08-02 陕西师范大学 一种引物组、检测血液样品种属的方法及应用
WO2020243579A1 (en) 2019-05-30 2020-12-03 10X Genomics, Inc. Methods of detecting spatial heterogeneity of a biological sample
AU2021283174A1 (en) 2020-06-02 2023-01-05 10X Genomics, Inc. Nucleic acid library methods
EP4600376A3 (en) 2020-06-02 2025-10-22 10X Genomics, Inc. Spatial transcriptomics for antigen-receptors
WO2021252499A1 (en) 2020-06-08 2021-12-16 10X Genomics, Inc. Methods of determining a surgical margin and methods of use thereof
CN115997123A (zh) * 2020-06-30 2023-04-21 国家医疗保健研究所 用于预测实体癌患者在术前辅助治疗后复发和/或死亡风险的方法
CN111951883A (zh) * 2020-08-04 2020-11-17 广东省第二人民医院(广东省卫生应急医院) 一种特征mRNA表达谱组合及结肠癌早期预测方法
CN115786518A (zh) * 2022-11-29 2023-03-14 广东医科大学附属医院 嗅素结构域家族蛋白4(olfm4)在结肠癌检测产品中的应用
WO2024206495A2 (en) * 2023-03-27 2024-10-03 Immunis.Ai, Inc. Active surveillance and risk stratification for prostate cancer
CN119372311A (zh) * 2024-09-30 2025-01-28 东南大学 基于成纤维细胞相关基因的结肠癌预后和治疗抵抗预测模型的构建方法和应用
CN120009551B (zh) * 2025-02-27 2025-08-15 西南医科大学 剪接因子wbp11及其抑制剂的用途、预防或治疗结直肠癌的药物

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155950B1 (en) 1983-09-02 1990-01-17 Molecular Biosystems, Inc. Oligonucleotide polymeric support system
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
EP0425563B1 (en) 1988-07-20 1996-05-15 David Segev Process for amplifying and detecting nucleic acid sequences
US5219727A (en) 1989-08-21 1993-06-15 Hoffmann-Laroche Inc. Quantitation of nucleic acids using the polymerase chain reaction
US5427930A (en) 1990-01-26 1995-06-27 Abbott Laboratories Amplification of target nucleic acids using gap filling ligase chain reaction
US5554501A (en) 1992-10-29 1996-09-10 Beckman Instruments, Inc. Biopolymer synthesis using surface activated biaxially oriented polypropylene
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
US5648211A (en) 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
WO1995030774A1 (en) 1994-05-05 1995-11-16 Beckman Instruments, Inc. Oligonucleotide repeat arrays
JP3881009B2 (ja) 1994-07-15 2007-02-14 バイオメリオ・ベー・ベー 核酸増幅方法を改良するためのrnaポリメラーゼの使用
AT402203B (de) 1995-06-13 1997-03-25 Himmler Gottfried Dipl Ing Dr Verfahren zur transkriptionsfreien amplifizierung von nucleinsäuren
US5716784A (en) 1996-02-05 1998-02-10 The Perkin-Elmer Corporation Fluorescence detection assay for homogeneous PCR hybridization systems
WO1997045559A1 (en) 1996-05-29 1997-12-04 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US5985567A (en) 1997-08-15 1999-11-16 Beckman Coulter, Inc. Hybridization detection by pretreating bound single-stranded probes
US6013789A (en) 1998-02-20 2000-01-11 Beckman Coulter, Inc. Covalent attachment of biomolecules to derivatized polypropylene supports
WO2001073027A2 (en) 2000-03-24 2001-10-04 Corixa Corporation Compositions and methods for therapy and diagnosis of colon cancer
WO2003062395A2 (en) * 2002-01-18 2003-07-31 Bristol-Myers Squibb Company Predictor sets for tyrosine kinase pathways
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
EP2213738B1 (en) * 2002-11-14 2012-10-10 Dharmacon, Inc. siRNA molecules targeting Bcl-2
CA2514187A1 (en) 2003-01-24 2004-08-12 Bayer Pharmaceuticals Corporation Expression profiles for colon cancer and methods of use
US20050287544A1 (en) * 2003-12-01 2005-12-29 Francois Bertucci Gene expression profiling of colon cancer with DNA arrays
WO2005068664A2 (en) 2004-01-09 2005-07-28 The Regents Of The University Of California Cell-type-specific patterns of gene expression
WO2005083128A2 (en) 2004-02-25 2005-09-09 University Of South Florida Methods for predicting cancer outcome and gene signatures for use therein
US20060195266A1 (en) 2005-02-25 2006-08-31 Yeatman Timothy J Methods for predicting cancer outcome and gene signatures for use therein
JP2008504018A (ja) 2004-06-03 2008-02-14 ジョンズ ホプキンス ユニバーシティ 細胞増殖または新生物性障害に関してスクリーニングする方法
AU2005300688B2 (en) 2004-11-03 2012-02-02 Almac Diagnostics Limited Transcriptome microarray technology and methods of using the same
CN101370946B (zh) 2005-10-21 2011-07-20 基因信息股份有限公司 用于使生物标志产物水平与疾病相关联的方法和装置
EP1974058B1 (en) * 2006-01-11 2014-06-11 Genomic Health, Inc. Gene expression markers for colorectal cancer prognosis
US20100009905A1 (en) * 2006-03-24 2010-01-14 Macina Roberto A Compositions and Methods for Detection, Prognosis and Treatment of Colon Cancer
WO2008093323A2 (en) * 2007-01-29 2008-08-07 Compugen Ltd. Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
NZ562237A (en) * 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
EP2285979B2 (en) 2008-05-27 2020-02-19 Dako Denmark A/S Hybridization compositions and methods
WO2010060055A1 (en) 2008-11-21 2010-05-27 Duke University Predicting cancer risk and treatment success

Similar Documents

Publication Publication Date Title
JP2014509189A5 (OSRAM)
JP7082380B2 (ja) 膵臓がんの検出キット又はデバイス及び検出方法
Robles et al. An integrated prognostic classifier for stage I lung adenocarcinoma based on mRNA, microRNA, and DNA methylation biomarkers
CN103403543B9 (zh) 结肠癌基因表达签名及使用方法
JP2014516543A5 (OSRAM)
JP2016509833A5 (OSRAM)
Gimondi et al. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation
CN103952474B (zh) 一种食管癌诊断标志物及其使用方法
CN104903468A (zh) 用于帕金森氏病的新诊断MiRNA标志物
US20160102359A1 (en) Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof
EP3122905B1 (en) Circulating micrornas as biomarkers for endometriosis
JP2016533708A5 (OSRAM)
Stokowy et al. Differences in miRNA and mRNA profile of papillary thyroid cancer variants
CN106661623A (zh) 使用miRNA生物标志物相对于多发性硬化诊断视神经脊髓炎
JP2015107091A (ja) 膵臓がんの検出キット及び検出方法
WO2023152568A2 (en) Compositions and methods for characterizing lung cancer
JP6200281B2 (ja) 甲状腺腫瘍の性状の判別を補助する方法およびその方法に用いるマーカーセット
JPWO2018123764A1 (ja) 神経芽腫の微小残存病変を評価するために用いられる試薬、およびそれを用いた生体試料の分析方法
CN106434893A (zh) 一种预测胃癌复发和铂类药物反应的lncRNA模型及其构建方法
Shivarov et al. Patient-specific microRNA expression profiles as a marker for minimal residual disease in acute myeloid leukemia
CN104726591B (zh) 可用于检测与大肠癌相关的SLCl9A1基因启动子区甲基化程度的试剂盒及其应用
CN104726592B (zh) 可用于检测与大肠癌相关的PCDH‑γ‑A12基因启动子区甲基化程度的试剂盒及其应用
JP2011152153A (ja) ガンのリンパ節転移またはそのリスクを判定する方法及びそのための迅速判定キット
JP2024086170A (ja) 分析方法、キット及び検出用デバイス
WO2014193522A1 (en) Biomolecular events in cancer revealed by attractor molecular signatures